USPTO serial 79291179
INDIFIELD
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 14, 2021
- Examiner
- STADELI, MARTA ANN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with INDIFIELD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Elizabeth M. O'Donoghue
Elizabeth M. O'Donoghue Armstrong Teasdale LLP7700 Forsyth BoulevardSuite 1800St. Louis, MO 63105Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical and biotechnological reagents for industrial and scientific purposes and laboratory analysis, and point-of-need, point-of-care, and on-site laboratory analysis, other than for medical or veterinary purposes; reagents and active solvents for scientific and research use, namely, sample preparation, modification and manipulation of cells and for labelling, separation, isolation, purification, amplification and analysis of natural and synthetic biopolymers, namely, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances, none of the forgoing for medical or veterinary purposes; chemicals or biochemical preparations used in industry, in particular chemical and biochemical substances for molecular biological, biochemical and immunological laboratory testing and analysis, other than for medical or veterinary purposes; biochemical reagent kits comprising biochemical reagents for scientific and research use, namely, for sample preparation, modification and manipulation of samples and cells as well as for labelling, separation, isolation, purification, amplification and analysis of natural or synthetic biopolymers, namely, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances, namely, nucleic acids from biological or biochemical sample material, none of the foregoing for medical or veterinary purposes; sample extraction kits comprising of containers in the nature of sealed and/or sealable plastic containers pre-filled with chemically active substances or other chemical reagents, namely, lysis, chemical washes and elution buffer solutions, and containing biologically or chemically active enzymes, magnetic beads being for the extraction of nucleic acids from different sample types, other than for medical or veterinary purposes; microplates pre-filled with reagents for the extraction and amplification of nucleic acids from different sample types, other than for medical or veterinary purposes; vials and tubes pre-filled with reagents for the extraction and amplification of nucleic acids, other than for medical or veterinary purposes; cartridges pre-filled with reagents for the extraction and amplification of nucleic acids, other than for medical or veterinary purposes; extraction kits comprised of chemical reagents for DNA, RNA or protein extraction, other than for medical or veterinary purposes; polymerase chain reaction (PCR) primer and probes being biochemical reagents for real-time polymerase chain reaction (PCR) and pen-side applications, namely, for detecting and analyzing molecules in protein, nucleotide or antigen arrays, other than for medical or veterinary purposes; nucleic acid primers, biochemical reagents being probes, and chemical reagents to support quantitative polymerase chain reaction (qPCR) assays, namely, for detecting and analyzing molecules in protein, nucleotide or antigen arrays, other than for medical or veterinary purposes | ACTIVE | — |
| 005 | Pharmaceutical and veterinary medical products as well as products for healthcare purposes, namely, diagnostic preparations for medical and veterinary purposes; diagnostic agents for medical, veterinary, laboratory medical and forensic purposes, namely, agents for in vitro diagnostics being in-vivo diagnostic agent used for detection and monitoring of angiogenesis and anti-angiogenic therapy; diagnostic agents for medical and veterinary purposes, namely, biological preparations for the treatment of infectious diseases in cattle, pigs, poultry and other animals; diagnostic preparations for medical and veterinary purposes; diagnostic kits consisting primarily of medical diagnostic reagents, oligonucleotides, antibodies, in-vitro medical diagnostic reagents and control reagents for medical purposes for use in disease testing; diagnostic kits consisting primarily of diagnostic test reagents for medical or veterinary use in in-vitro diagnostic and applications, namely, diagnosis and confirmation of mammalian species; products for medical and veterinary medical purposes, namely, diagnostic preparations for sample preparation, modification and manipulation of cells and for labelling, separation, isolation, purification, amplification and analysis of natural and synthetic biopolymers, namely, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances; chemical, biochemical and biotechnological products for medical or veterinary purposes, namely, reagents and solvents for sample preparation, modification and manipulation of cells; in vitro diagnostic preparations for medical purposes; diagnostic kits for medical and veterinary purposes comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, diseases caused by viral, bacterial and parasitological pathogens including African Swine Fever Virus, Porcine Reproductive and Respiratory Syndrome Virus; veterinary diagnostic reagents; chemical test reagents for veterinary purposes; chemical reagents for veterinary purposes; medical diagnostic kits consisting primarily of medical diagnostic reagents and also containing oligonucleotides, antibodies, in-vitro diagnostic preparations and control reagents for biochemical, molecular biological and immunological testing; medical diagnostic test strips for fecal analysis, blood analysis, urine analysis, serum analysis, oral fluid analysis, saliva analysis, tissue aspirates analysis and bovine milk analysis | ACTIVE | — |
| 009 | Laboratory apparatus and instruments for molecular biological and immunological test systems for scientific research, namely, laboratory testing kits for testing multiplex polymerase chain reaction (PCR) comprising of laboratory devices for removing, marking, applying and identifying biological or biochemical samples for scientific research, sequencing apparatus for the purpose of detecting DNA and RNA sequences in polymerase chain reaction (PCR) cyclers and also including associated computer hardware and recorded operating software, sold as a unit for scientific research purposes; scientific apparatus and instruments, namely, manual and semi-automatic instruments for extracting nucleic acids from fluid sample material including blood, serum, tissue fluids, saliva, oral fluids and milk; apparatus and instruments for scientific research in laboratories, namely, manual and semi- automatic instruments for extracting nucleic acids from fluid sample material including blood, serum, tissue fluids, saliva, oral fluids and milk; laboratory apparatus and instruments being test equipment for use in in-vitro diagnostics, not for medical purposes; molecular biological testing systems for scientific research, namely, laboratory kits for testing multiplex polymerase chain reaction (PCR) for scientific research comprising of electronic analyzers for testing and analysing nucleic structures, scientific instrumentation for measuring the quantity of proteins, antigens and nucleic acids in a sample, including hardware and recorded operating software for analysing multiplex polymerase chain reaction (PCR), and computer hardware and downloadable cloud-based software for storing, managing and analysing electronic data, all sold as a unit for use in scientific research; scientific instruments for measuring relative nucleic acid (DNA and RNA), not for medical use; observation instruments for detecting nucleic acid (DNA and RNA); laboratory apparatus and instruments for testing for nucleic acid (DNA and RNA) not for medical purposes; laboratory equipment, namely, glass and plastic tubes and vials for scientific purposes; laboratory consumables, namely, pipette tips, cartridges, syringes; laboratory pipettes; pipette racks for laboratory use; pipette tips for laboratory use; laboratory equipment, namely, tubes and vials for scientific use; cell culture plates for laboratory use; scientific instruments for quantitative polymerase chain reaction (PCR), namely, real-time PCR cyclers | ACTIVE | — |
| 010 | Medical diagnostic apparatus for testing and analysing biological samples for blood sugar levels, DNA, RNA, protein and antigens; analysis apparatus for nucleic acid (DNA and RNA) testing for medical purposes; medical diagnostic apparatus for testing nucleic acid (DNA and RNA) samples; medical apparatus for clinical diagnostics for testing nucleic acid (DNA and RNA); laboratory plasticware for use in in-vitro diagnostics for medical purposes, namely, sample preparation device for medical diagnostic uses; medical instruments, namely, quantitative polymerase chain reaction (PCR) instruments for detection of pathogen nucleic acids; cartridge for medical diagnostics for use in in-vitro diagnostics, namely, sample preparation device for medical diagnostic uses; disposable cartridge for medical diagnostics in in-vitro diagnostics, namely, sample preparation device for medical diagnostic uses | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by INDICAL BIOSCIENCE GmbH
- Other trademarks owned by INDICAL BIOSCIENCE GmbH
- Other trademarks owned by INDICAL BIOSCIENCE GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named INDIFIELD
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 14, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 8, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Oct 8, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 8, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 8, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 23, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 23, 2022 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Sep 23, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 23, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 21, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 27, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 26, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 14, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 14, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 29, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 29, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 9, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 22, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 6, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 6, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 6, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 3, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 3, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 3, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 16, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 16, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 16, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 15, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 15, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 15, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 15, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 15, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 4, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 17, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 16, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 21, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 20, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 12, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 8, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 8, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 6, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |